The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Open accessAbstract
HBV infection remains a leading cause of death worldwide. IFN-α inhibits viral replication in vitro and in vivo, and pegylated IFN-α is a commonly administered treatment for individuals infected with HBV. The HBV genome contains a typical IFN-stimulated response element (ISRE), but the molecular mechanisms by which IFN-α suppresses HBV replication have not been established in relevant experimental systems. Here, we show that IFN-α inhibits HBV replication by decreasing the transcription of pregenomic RNA (pgRNA) and subgenomic RNA from the HBV covalently closed circular DNA (cccDNA) minichromosome, both in cultured cells in which HBV is replicating and in mice whose livers have been repopulated with human hepatocytes and infected with HBV. Administration of IFN-α resulted in cccDNA-bound histone hypoacetylation as well as active recruitment to the cccDNA of transcriptional corepressors. IFN-α treatment also reduced binding of the STAT1 and STAT2 transcription factors to active cccDNA. The inhibitory activity of IFN-α was linked to the IRSE, as IRSE-mutant HBV transcribed less pgRNA and could not be repressed by IFN-α treatment. Our results identify a molecular mechanism whereby IFN-α mediates epigenetic repression of HBV cccDNA transcriptional activity, which may assist in the development of novel effective therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferon-inducible antiviral effectors
Sadler, A. J., & Williams, B. R. G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2314 · Cited by 2,160
EASL clinical practice guidelines management of chronic hepatitis B
张学武, & Li, X. (2009) · Inter J Epidemiol Infect Dis · doi:10.3760/cma.j.issn.1673-4149.2009.04.001 · Cited by 1,506
Robertson, G., Hirst, M., Bainbridge, M., Bilenky, M., Zhao, Y., Zeng, T., Euskirchen, G., Bernier, B., Varhol, R., Delaney, A., et al. (2007) · Nature Methods · doi:10.1038/nmeth1068 · Cited by 1,454
EASL Clinical Practice Guidelines: Management of chronic hepatitis B
European Association for the Study of the Liver (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.10.001 · Cited by 1,347
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology
Gordon, S., Akopyan, G., Garban, H., & Bonavida, B. (2006) · Oncogene · doi:10.1038/sj.onc.1209080 · Cited by 756
Caretti, G., Di Padova, M., Micales, B., Lyons, G. E., & Sartorelli, V. (2004) · Genes & Development · doi:10.1101/gad.1241904 · Cited by 600
Control of cccDNA function in hepatitis B virus infection
Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.022 · Cited by 552
Günther, S., Li, B. C., Miska, S., Krüger, D. H., Meisel, H., & Will, H. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5437-5444.1995 · Cited by 499
Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function
Belloni, L., Pollicino, T., De Nicola, F., Guerrieri, F., Raffa, G., Fanciulli, M., Raimondo, G., & Levrero, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908365106 · Cited by 498
Self-citationHepatitis B virus X protein is essential to initiate and maintain virus replication after infection
Lucifora, J., Arzberger, S., Durantel, D., Belloni, L., Strubin, M., Levrero, M., Zoulim, F., Hantz, O., & Protzer, U. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.02.015 · Cited by 481
Self-citationPollicino, T., Belloni, L., Raffa, G., Pediconi, N., Squadrito, G., Raimondo, G., & Levrero, M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.001 · Cited by 472
Self-citationPetersen, J., Dandri, M., Mier, W., Lütgehetmann, M., Volz, T., von Weizsäcker, F., Haberkorn, U., Fischer, L., Pollok, J.-M., Erbes, B., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1389 · Cited by 397
Self-citationPalacios, D., Mozzetta, C., Consalvi, S., Caretti, G., Saccone, V., Proserpio, V., Marquez, V. E., Valente, S., Mai, A., Forcales, S. V., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.013 · Cited by 392
Hepatitis B viruses: Reverse transcription a different way
Nassal, M. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.024 · Cited by 382
Wieland, S. F., Guidotti, L. G., & Chisari, F. V. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4165-4173.2000 · Cited by 243
Volz, T., Lutgehetmann, M., Wachtler, P., Jacob, A., Quaas, A., Murray, J. M., Dandri, M., & Petersen, J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.057 · Cited by 195
Self-citationHepatitis B Virus Limits Response of Human Hepatocytes to Interferon-α in Chimeric Mice
Lütgehetmann, M., Bornscheuer, T., Volz, T., Allweiss, L., Bockmann, J. H., Pollok, J. M., Lohse, A. W., Petersen, J., & Dandri, M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.057 · Cited by 159
Self-citationInterferons Accelerate Decay of Replication-Competent Nucleocapsids of Hepatitis B Virus
Xu, C., Guo, H., Pan, X., Mao, R., Yu, W., Xu, X., Wei, L., Chang, J., Block, T. M., & Guo, J. (2010) · Journal of Virology · doi:10.1128/jvi.00918-10 · Cited by 135
Li, J., Lin, S., Chen, Q., Peng, L., Zhai, J., Liu, Y., & Yuan, Z. (2010) · Journal of Virology · doi:10.1128/jvi.00236-10 · Cited by 94
p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc
Sankar, N., Baluchamy, S., Kadeppagari, R., Singhal, G., Weitzman, S. A., & Thimmapaya, B. (2008) · Oncogene · doi:10.1038/onc.2008.181 · Cited by 89
Transcriptional and posttranscriptional control of hepatitis B virus gene expression
Uprichard, S. L., Wieland, S. F., Althage, A., & Chisari, F. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252773599 · Cited by 84
Conditional Replication of Duck Hepatitis B Virus in Hepatoma Cells
Guo, J., Pryce, M., Wang, X., Barrasa, M. I., Hu, J., & Seeger, C. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.1885-1893.2003 · Cited by 74
Rang, A., Günther, S., & Will, H. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80279-7 · Cited by 73
Lütgehetmann, M., Volz, T., Quaas, A., Zankel, M., Fischer, C., Dandri, M., & Petersen, J. (2008) · Antiviral Therapy · doi:10.1177/135965350801300106 · Cited by 68
Self-citationVirion half‐life in chronic hepatitis B infection is strongly correlated with levels of viremia†
Dandri, M., Murray, J. M., Lütgehetmann, M., Volz, T., Lohse, A. W., & Petersen, J. (2008) · Hepatology · doi:10.1002/hep.22469 · Cited by 67
Self-citationTestoni, B., Voellenkle, C., Guerrieri, F., Gerbal‐Chaloin, S., Blandino, G., & Levrero, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231068 · Cited by 64
Self-citationAlpha interferon suppresses hepatitis B virus enhancer activity and reduces viral gene transcription
Tur‐Kaspa, R., Teicher, L., Laub, O., Itin, A., Dagan, D., Bloom, B. R., & Shafritz, D. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.4.1821-1824.1990 · Cited by 60
Caselmann, W. H., Meyer, M., Scholz, S., HOFSCHNEIDER, P. H., & Koshy, R. (1992) · The Journal of Infectious Diseases · doi:10.1093/infdis/166.5.966 · Cited by 36
Alcantara, F. F., Tang, H., & McLachlan, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.2068 · Cited by 35
Nakanishi‐Matsui, M., Hayashi, Y., Kitamura, Y., & Koike, K. (2000) · Journal of Virology · doi:10.1128/jvi.74.12.5562-5568.2000 · Cited by 20
Cited by
Shared and Distinct Functions of Type I and Type III Interferons
Lazear, H. M., Schoggins, J. W., & Diamond, M. S. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.025 · Cited by 1,138
Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA
Lucifora, J., Xia, Y., Reisinger, F., Zhang, K., Stadler, D., Cheng, X., Sprinzl, M. F., Koppensteiner, H., Makowska, Z., Volz, T., et al. (2014) · Science · doi:10.1126/science.1243462 · Cited by 893
Self-citationTherapeutic strategies for hepatitis B virus infection: towards a cure
Fanning, G. C., Zoulim, F., Hou, J., & Bertoletti, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0037-0 · Cited by 557
A global scientific strategy to cure hepatitis B
Revill, P. A., Chisari, F. V., Block, J. M., Dandri, M., Gehring, A. J., Guo, H., Hu, J., Kramvis, A., Lampertico, P., Janssen, H. L. A., et al. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30119-0 · Cited by 508
Self-citationHepatitis B virus biology and life cycle
Tsukuda, S., & Watashi, K. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104925 · Cited by 376
Metadata
- Authors
- Belloni, L., Allweiss, L., Guerrieri, F., Pediconi, N., Volz, T., Pollicino, T., Petersen, J., Raimondo, G., Dandri, M., & Levrero, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-02-01
- Volume
- 122
- Issue
- 2
- Pages
- 529-537
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2015763479
- Cited by
- 577
- References
- 30
- FWCI
- 28.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.